Global Immuno-oncology Therapy Market Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
At the beginning of 2020, COVID-19 disease began to spread around the world, millions of people worldwide were infected with COVID-19 disease, and major countries around the world have implemented foot prohibitions and work stoppage orders. Except for the medical supplies and life support products industries, most industries have been greatly impacted, and Immuno-oncology Therapy industries have also been greatly affected.
In the past few years, the Immuno-oncology Therapy market experienced a growth of xx, the global market size of Immuno-oncology Therapy reached 1288.0 million $ in 2020, of what is about xx million $ in 2015.
From 2015 to 2019, the growth rate of global Immuno-oncology Therapy market size was in the range of xxx%. At the end of 2019, COVID-19 began to erupt in China, Due to the huge decrease of global economy; we forecast the growth rate of global economy will show a decrease of about 4%, due to this reason, Immuno-oncology Therapy market size in 2020 will be 1288.0 with a growth rate of xxx%. This is xxx percentage points lower than in previous years.
As of the date of the report, there have been more than 20 million confirmed cases of CVOID-19 worldwide, and the epidemic has not been effectively controlled. Therefore, we predict that the global epidemic will be basically controlled by the end of 2020 and the global Immuno-oncology Therapy market size will reach 1596.0 million $ in 2025, with a CAGR of xxx% between 2020-2025.
This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.
Section 1: Free——Definition
Section (2 3): 1200 USD——Manufacturer Detail
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda
BioNTech SE
Allogene Therapeutics
IMAB-I-Mab Biopharma Co., Ltd.
Arcus Biosciences
Gritstone Oncology
Autolus Therapeutics
Rubius Therapeutics
Section 4: 900 USD——Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7): 500 USD——
Product Type Segmentation
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Industry Segmentation
Hospitals
Ambulatory Surgical Center
Channel (Direct Sales, Distributor) Segmentation
Section 8: 400 USD——Trend (2020-2025)
Section 9: 300 USD——Product Type Detail
Section 10: 700 USD——Downstream Consumer
Section 11: 200 USD——Cost Structure
Section 12: 500 USD——Conclusion
Section 1 Immuno-oncology Therapy Product Definition
Section 2 Global Immuno-oncology Therapy Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Immuno-oncology Therapy Shipments
2.2 Global Manufacturer Immuno-oncology Therapy Business Revenue
2.3 Global Immuno-oncology Therapy Market Overview
2.4 COVID-19 Impact on Immuno-oncology Therapy Industry
Section 3 Manufacturer Immuno-oncology Therapy Business Introduction
3.1 Amgen Immuno-oncology Therapy Business Introduction
3.1.1 Amgen Immuno-oncology Therapy Shipments, Price, Revenue and Gross profit 2015-2020
3.1.2 Amgen Immuno-oncology Therapy Business Distribution by Region
3.1.3 Amgen Interview Record
3.1.4 Amgen Immuno-oncology Therapy Business Profile
3.1.5 Amgen Immuno-oncology Therapy Product Specification
3.2 AstraZeneca Immuno-oncology Therapy Business Introduction
3.2.1 AstraZeneca Immuno-oncology Therapy Shipments, Price, Revenue and Gross profit 2015-2020
3.2.2 AstraZeneca Immuno-oncology Therapy Business Distribution by Region
3.2.3 Interview Record
3.2.4 AstraZeneca Immuno-oncology Therapy Business Overview
3.2.5 AstraZeneca Immuno-oncology Therapy Product Specification
3.3 Bristol-Myers Squibb Immuno-oncology Therapy Business Introduction
3.3.1 Bristol-Myers Squibb Immuno-oncology Therapy Shipments, Price, Revenue and Gross profit 2015-2020
3.3.2 Bristol-Myers Squibb Immuno-oncology Therapy Business Distribution by Region
3.3.3 Interview Record
3.3.4 Bristol-Myers Squibb Immuno-oncology Therapy Business Overview
3.3.5 Bristol-Myers Squibb Immuno-oncology Therapy Product Specification
3.4 Eli-Lilly Immuno-oncology Therapy Business Introduction
3.5 Roche Immuno-oncology Therapy Business Introduction
3.6 GlaxoSmithKline Immuno-oncology Therapy Business Introduction
…
Section 4 Global Immuno-oncology Therapy Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Immuno-oncology Therapy Market Size and Price Analysis 2015-2020
4.1.2 Canada Immuno-oncology Therapy Market Size and Price Analysis 2015-2020
4.2 South America Country
4.2.1 South America Immuno-oncology Therapy Market Size and Price Analysis 2015-2020
4.3 Asia Country
4.3.1 China Immuno-oncology Therapy Market Size and Price Analysis 2015-2020
4.3.2 Japan Immuno-oncology Therapy Market Size and Price Analysis 2015-2020
4.3.3 India Immuno-oncology Therapy Market Size and Price Analysis 2015-2020
4.3.4 Korea Immuno-oncology Therapy Market Size and Price Analysis 2015-2020
4.4 Europe Country
4.4.1 Germany Immuno-oncology Therapy Market Size and Price Analysis 2015-2020
4.4.2 UK Immuno-oncology Therapy Market Size and Price Analysis 2015-2020
4.4.3 France Immuno-oncology Therapy Market Size and Price Analysis 2015-2020
4.4.4 Italy Immuno-oncology Therapy Market Size and Price Analysis 2015-2020
4.4.5 Europe Immuno-oncology Therapy Market Size and Price Analysis 2015-2020
4.5 Other Country and Region
4.5.1 Middle East Immuno-oncology Therapy Market Size and Price Analysis 2015-2020
4.5.2 Africa Immuno-oncology Therapy Market Size and Price Analysis 2015-2020
4.5.3 GCC Immuno-oncology Therapy Market Size and Price Analysis 2015-2020
4.6 Global Immuno-oncology Therapy Market Segmentation (Region Level) Analysis 2015-2020
4.7 Global Immuno-oncology Therapy Market Segmentation (Region Level) Analysis
Section 5 Global Immuno-oncology Therapy Market Segmentation (Product Type Level)
5.1 Global Immuno-oncology Therapy Market Segmentation (Product Type Level) Market Size 2015-2020
5.2 Different Immuno-oncology Therapy Product Type Price 2015-2020
5.3 Global Immuno-oncology Therapy Market Segmentation (Product Type Level) Analysis
Section 6 Global Immuno-oncology Therapy Market Segmentation (Industry Level)
6.1 Global Immuno-oncology Therapy Market Segmentation (Industry Level) Market Size 2015-2020
6.2 Different Industry Price 2015-2020
6.3 Global Immuno-oncology Therapy Market Segmentation (Industry Level) Analysis
Section 7 Global Immuno-oncology Therapy Market Segmentation (Channel Level)
7.1 Global Immuno-oncology Therapy Market Segmentation (Channel Level) Sales Volume and Share 2015-2020
7.2 Global Immuno-oncology Therapy Market Segmentation (Channel Level) Analysis
Section 8 Immuno-oncology Therapy Market Forecast 2020-2025
8.1 Immuno-oncology Therapy Segmentation Market Forecast (Region Level)
8.2 Immuno-oncology Therapy Segmentation Market Forecast (Product Type Level)
8.3 Immuno-oncology Therapy Segmentation Market Forecast (Industry Level)
8.4 Immuno-oncology Therapy Segmentation Market Forecast (Channel Level)
Section 9 Immuno-oncology Therapy Segmentation Product Type
9.1 Monoclonal Antibodies Product Introduction
9.2 Immune Checkpoint Inhibitors Product Introduction
9.3 Immune System Modulators Product Introduction
9.4 Cancer Vaccines Product Introduction
Section 10 Immuno-oncology Therapy Segmentation Industry
10.1 Hospitals Clients
10.2 Ambulatory Surgical Center Clients
Section 11 Immuno-oncology Therapy Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview
Section 12 Conclusion
Chart and Figure
Figure Immuno-oncology Therapy Product Picture from Amgen
Chart 2015-2020 Global Manufacturer Immuno-oncology Therapy Shipments (Units)
Chart 2015-2020 Global Manufacturer Immuno-oncology Therapy Shipments Share
Chart 2015-2020 Global Manufacturer Immuno-oncology Therapy Business Revenue (Million USD)
Chart 2015-2020 Global Manufacturer Immuno-oncology Therapy Business Revenue Share
Chart Amgen Immuno-oncology Therapy Shipments, Price, Revenue and Gross profit 2015-2020
Chart Amgen Immuno-oncology Therapy Business Distribution
Chart Amgen Interview Record (Partly)
Figure Amgen Immuno-oncology Therapy Product Picture
Chart Amgen Immuno-oncology Therapy Business Profile
Table Amgen Immuno-oncology Therapy Product Specification
Chart AstraZeneca Immuno-oncology Therapy Shipments, Price, Revenue and Gross profit 2015-2020
Chart AstraZeneca Immuno-oncology Therapy Business Distribution
Chart AstraZeneca Interview Record (Partly)
Figure AstraZeneca Immuno-oncology Therapy Product Picture
Chart AstraZeneca Immuno-oncology Therapy Business Overview
Table AstraZeneca Immuno-oncology Therapy Product Specification
Chart Bristol-Myers Squibb Immuno-oncology Therapy Shipments, Price, Revenue and Gross profit 2015-2020
Chart Bristol-Myers Squibb Immuno-oncology Therapy Business Distribution
Chart Bristol-Myers Squibb Interview Record (Partly)
Figure Bristol-Myers Squibb Immuno-oncology Therapy Product Picture
Chart Bristol-Myers Squibb Immuno-oncology Therapy Business Overview
Table Bristol-Myers Squibb Immuno-oncology Therapy Product Specification
3.4 Eli-Lilly Immuno-oncology Therapy Business Introduction
…
Chart United States Immuno-oncology Therapy Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart United States Immuno-oncology Therapy Sales Price ($/Unit) 2015-2020
Chart Canada Immuno-oncology Therapy Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Canada Immuno-oncology Therapy Sales Price ($/Unit) 2015-2020
Chart South America Immuno-oncology Therapy Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart South America Immuno-oncology Therapy Sales Price ($/Unit) 2015-2020
Chart China Immuno-oncology Therapy Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart China Immuno-oncology Therapy Sales Price ($/Unit) 2015-2020
Chart Japan Immuno-oncology Therapy Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Japan Immuno-oncology Therapy Sales Price ($/Unit) 2015-2020
Chart India Immuno-oncology Therapy Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart India Immuno-oncology Therapy Sales Price ($/Unit) 2015-2020
Chart Korea Immuno-oncology Therapy Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Korea Immuno-oncology Therapy Sales Price ($/Unit) 2015-2020
Chart Germany Immuno-oncology Therapy Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Germany Immuno-oncology Therapy Sales Price ($/Unit) 2015-2020
Chart UK Immuno-oncology Therapy Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart UK Immuno-oncology Therapy Sales Price ($/Unit) 2015-2020
Chart France Immuno-oncology Therapy Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart France Immuno-oncology Therapy Sales Price ($/Unit) 2015-2020
Chart Italy Immuno-oncology Therapy Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Italy Immuno-oncology Therapy Sales Price ($/Unit) 2015-2020
Chart Europe Immuno-oncology Therapy Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Europe Immuno-oncology Therapy Sales Price ($/Unit) 2015-2020
Chart Middle East Immuno-oncology Therapy Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Middle East Immuno-oncology Therapy Sales Price ($/Unit) 2015-2020
Chart Africa Immuno-oncology Therapy Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Africa Immuno-oncology Therapy Sales Price ($/Unit) 2015-2020
Chart GCC Immuno-oncology Therapy Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart GCC Immuno-oncology Therapy Sales Price ($/Unit) 2015-2020
Chart Global Immuno-oncology Therapy Market Segmentation (Region Level) Sales Volume 2015-2020
Chart Global Immuno-oncology Therapy Market Segmentation (Region Level) Market size 2015-2020
Chart Immuno-oncology Therapy Market Segmentation (Product Type Level) Volume (Units) 2015-2020
Chart Immuno-oncology Therapy Market Segmentation (Product Type Level) Market Size (Million $) 2015-2020
Chart Different Immuno-oncology Therapy Product Type Price ($/Unit) 2015-2020
Chart Immuno-oncology Therapy Market Segmentation (Industry Level) Market Size (Volume) 2015-2020
Chart Immuno-oncology Therapy Market Segmentation (Industry Level) Market Size (Share) 2015-2020
Chart Immuno-oncology Therapy Market Segmentation (Industry Level) Market Size (Value) 2015-2020
Chart Global Immuno-oncology Therapy Market Segmentation (Channel Level) Sales Volume (Units) 2015-2020
Chart Global Immuno-oncology Therapy Market Segmentation (Channel Level) Share 2015-2020
Chart Immuno-oncology Therapy Segmentation Market Forecast (Region Level) 2020-2025
Chart Immuno-oncology Therapy Segmentation Market Forecast (Product Type Level) 2020-2025
Chart Immuno-oncology Therapy Segmentation Market Forecast (Industry Level) 2020-2025
Chart Immuno-oncology Therapy Segmentation Market Forecast (Channel Level) 2020-2025
Chart Monoclonal Antibodies Product Figure
Chart Monoclonal Antibodies Product Advantage and Disadvantage Comparison
Chart Immune Checkpoint Inhibitors Product Figure
Chart Immune Checkpoint Inhibitors Product Advantage and Disadvantage Comparison
Chart Immune System Modulators Product Figure
Chart Immune System Modulators Product Advantage and Disadvantage Comparison
Chart Cancer Vaccines Product Figure
Chart Cancer Vaccines Product Advantage and Disadvantage Comparison
Chart Hospitals Clients
Chart Ambulatory Surgical Center Clients
Research Methodology:
Immuno oncology Therapy Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|